Haruspex AI Analysis
Analyzed for: swing
Bullish — AbbVie Inc. (ABBV) shows strong momentum with an overall score of 71/100. Strength in Short Interest & Lending Intellig...
Momentum: +1 improving
Short Interest & Lending Intelligence
Score 65/100 · Change +0Institutional Ownership Intelligence
Score 50/100 · Change +0AbbVie Inc. (ABBV) shows strong momentum with an overall score of 71/100. Strength in Short Interest & Lending Intelligence (65) is complemented by Institutional Ownership Intelligence (50). Position sizing should reflect the current bullish outlook.
Short Interest & Lending Intelligence
65/100 · +0Moderate
Full confidence framework unlocks after signup.Overall Outlook: Bullish
Strongest Area: Short Interest & Lending Intelligence (65/100)
Main Concern: Institutional Ownership Intelligence (50/100)
Price Movement: Low — Pretty stable
Drivers: Short interest -99.9% vs prior month | Overall short sentiment: bullish | 1.4% of float shorted
Risks: 5,239 institutional holders | 77.5% institutional ownership | Buy/sell ratio: 0.23 (net -102,351.158 shares)
Timeline Outlook: AbbVie Inc. (ABBV) shows strong momentum with an overall score of 71/100. Strength in Short Interest & Lending Intelligence (65) is complemented by Institutional Ownership Intelligence (50). Position sizing should reflect the current bullish outlook.
What to watch:
Score: 61/100
Confidence: High confidence
low impactCompetitive Intelligence currently adds bullish pressure for ABBV. AbbVie Inc operates in the Drug Manufacturers - General industry, ranking #2 by market cap among 5 peers. Profitability exceeds industry peers. Watch market leader JNJ for competitive moves to confirm or weaken this signal.
Key drivers:
Signal: Above Average (change: +0)
Score: 63/100
Confidence: Moderate confidence
low impactEarnings Intelligence currently adds bullish pressure for ABBV. AbbVie Inc. beat EPS estimates by 4.2%. Watch follow-through in earnings intelligence signals to confirm or weaken this signal.
Key drivers:
Signal: Above Average (change: +0)
Score: 50/100
Confidence: High confidence
low impactInstitutional Ownership Intelligence currently is a neutral-to-mixed signal for ABBV. ABBV has 77.5% institutional ownership across 5,239 institutions . Net institutional selling detected. Monitor for continued institutional selling to confirm or weaken this signal.
Key drivers:
Signal: Average (change: +0)
Score: 64/100
Confidence: High confidence
low impactMarket Microstructure currently creates bearish pressure for ABBV. ABBV with balanced order flow. Excellent liquidity with tight spreads. Monitor volume and order flow for directional signals to confirm or weaken this signal.
Key drivers:
Signal: Above Average (change: +0)
Score: 63/100
Confidence: High confidence
low impactOptions Flow Intelligence currently adds bullish pressure for ABBV. AbbVie Inc. options show bullish sentiment with P/C ratio of 0.32. Watch low put/call ratio indicates bullish sentiment to confirm or weaken this signal.
Key drivers:
Signal: Above Average (change: +0)
Score: 64/100
Confidence: Moderate confidence
low impactAlgorithmic sentiment analysis for ABBV. AI analysis unavailable. The main reasons are Based on news sentiment scores; Based on retail sentiment data. That is why market sentiment currently leans favorable for the stock at 64/100. What to watch next: Monitor news sentiment changes.
Key drivers:
Signal: Above Average (change: +0)
Score: 65/100
Confidence: High confidence
low impactShort Interest & Lending Intelligence currently adds bullish pressure for ABBV. AbbVie Inc. has 1.4% of float shorted, down 99.9% from prior month. Watch short covering in progress - potential bullish signal to confirm or weaken this signal.
Key drivers:
Signal: Above Average (change: +0)
Score: 63/100
Confidence: Moderate confidence
low impactTechnical Analysis currently adds bullish pressure for ABBV. AbbVie Inc. at $261.83 (1M, swing context) is in a bullish trend (golden cross). Track momentum follow-through and catalyst reaction over the next 1-2 weeks to confirm or weaken this signal.
Key drivers:
Signal: Above Average (change: +0)
Research, development, manufacturing, and commercialization of biopharmaceutical products.
Profile Refresh: Feb 23, 2026
Item 1A, "Risk Factors - AbbVie depends on information technology and a failure of, or significant disruption to, those systems could have a material adverse effect on AbbVie's business." Our board of directors has risk oversight responsibility for AbbVie and administers this responsibility both directly and with assistance from its committees. Each of the committees periodically reports to the board of directors on its risk oversight activities. Cybersecurity is a critical component of our enterprise risk management program, which is designed to be business aligned, risk-focused and multi-faceted to protect our and our patients', customers' and business partners' data. Our board of directors is actively involved in reviewing our information security and technology risks and opportunities...
Top-scored stocks, biggest movers, and what the board flagged — one email, every Monday. No spam, unsubscribe anytime.
Send the bot a ticker — AAPL, NVDA, anything — and get its Haruspex score, signals and outlook back in seconds. Free.
Open the Telegram botor follow @haruspex_alerts for the daily top-scored pick.